Skip to content
HeyJared

PharmaVoice

PharmaVoice is a specialized business and news outlet focused on the pharmaceutical and biotechnology industries, with an emphasis on strategy, policy, and market-moving developments.

Outlet · Official site

Indexed articles, last 90 days
39
Latest publication
Sep 29, 2026
Audience
Top 5M sites
Earliest in this view
Jul 6, 2026

Latest articles

  1. Article · Sep 29, 2026 · Kelly Bilodeau

    Epilepsy R&D is breaking out of its old playbook (opens the original)

    Excerpt

    Read excerpt

    Genetic medicines and more selective small molecules are finally pushing the field toward new mechanisms — and potentially disease-modifying treatments.

  2. Article · Sep 28, 2026 · Alexandra Pecci

    What Bavarian Nordic’s next CEO is up against (opens the original)

    Excerpt

    Read excerpt

    The Danish biotech sharpened its global vaccine ambitions by tapping Tarja Stenvall, a Big Pharma vet, to take the helm.

  3. Article · Sep 25, 2026 · Alexandra Pecci

    Nimbus used AI to help develop Takeda’s $4B psoriasis bet. Here’s where it’s taking the tech next (opens the original)

    Excerpt

    Read excerpt

    Nimbus Therapeutics’ head of R&D dishes on what’s next in AI-enabled drug discovery, years after Takeda completed its zasocitinib acquisition.

  4. Article · Sep 25, 2026 · PharmaVoice Staff

    Basecamp raises $140M before the clinic; J&J and Compass’ potential rivalry (opens the original)

    Excerpt

    Read excerpt

    Some of the biggest news and trends captured in PharmaVoice’s newsletter this week. Sign up here to receive the newsletter daily. Another big AI haul Investors are still lining up to back AI drug developers before their candidates reach human trials. Basecamp Research...

  5. Article · Sep 24, 2026 · Jonathan Gardner

    Where does FDA nominee Overton stand on vaccines and other key pharma issues? (opens the original)

    Excerpt

    Read excerpt

    Pressed by lawmakers on Thursday, Trump’s pick as the next FDA chief said she’d “follow the law” on vaccine-related decisions and work to speed early drug R&D.

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 5M sites

Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

How this was measured

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about PharmaVoice